Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
14 23 Search
2024
IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells
Cellular Oncology
2024
The therapeutic potential of natural metabolites in targeting endocrine-independent HER-2-negative breast cancer
Frontiers in Pharmacology
2023
Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer
International Journal of Molecular Sciences
2023
Natural-Product-Derived Adjunctive Treatments to Conventional Therapy and Their Immunoregulatory Activities in Triple-Negative Breast Cancer
Molecules
2023
Ginsenosides: changing the basic hallmarks of cancer cells to achieve the purpose of treating breast cancer
Chinese Medicine
2022
Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer
Frontiers in Pharmacology
2022
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivity
Journal of Cellular Physiology
2022
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Journal of Hematology & Oncology
2022
Ginsenosides: Allies of gastrointestinal tumor immunotherapy
Frontiers in Pharmacology
2022
Zinc complex of 3,5-di-tert-butyl salicylate inhibits viability, migration, and invasion in triple-negative breast cancer cells
Scientific Reports
2021
7-Epitaxol Induces Apoptosis and Autophagy in Head and Neck Squamous Cell Carcinoma through Inhibition of the ERK Pathway
Cells
2021
Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
Frontiers in Pharmacology
2021
Curcumin Reverses NNMT-Induced 5-Fluorouracil Resistance via Increasing ROS and Cell Cycle Arrest in Colorectal Cancer Cells
Biomolecules
2021
Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy
Frontiers in Pharmacology
Additional cited-by details will be shown when available from Crossref